223 related articles for article (PubMed ID: 31992275)
1. Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry.
Souliotis K; Koutsovasilis A; Vatheia G; Golna C; Nikolaidi S; Hatziagelaki E; Kotsa K; Koufakis T; Melidonis A; Papazafiropoulou A; Tentolouris N; Siami E; Sotiropoulos A
BMC Endocr Disord; 2020 Jan; 20(1):16. PubMed ID: 31992275
[TBL] [Abstract][Full Text] [Related]
2. A Greek registry of current type 2 diabetes management, aiming to determine core clinical approaches, patterns and strategies.
Liatis S; Iraklianou S; Kazakos K; Mastorakos G; Milios K; Mouslech Z; Noutsou M; Pagkalos E; Sampanis C;
BMC Endocr Disord; 2019 Apr; 19(1):39. PubMed ID: 31023374
[TBL] [Abstract][Full Text] [Related]
3. Extent and Predictors of Poor Glycaemic Control among Elderly Pakistani Patients with Type 2 Diabetes Mellitus: A Multi-Centre Cross-Sectional Study.
Atif M; Saleem Q; Asghar S; Malik I; Ahmad N
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658518
[No Abstract] [Full Text] [Related]
4. Predictors of poor glycaemic control in older patients with type 2 diabetes mellitus.
Sazlina SG; Mastura I; Cheong AT; Bujang Mohamad A; Jamaiyah H; Lee PY; Syed Alwi SA; Chew BH
Singapore Med J; 2015 May; 56(5):284-90. PubMed ID: 25814074
[TBL] [Abstract][Full Text] [Related]
5. Determinants for inadequate glycaemic control in Chinese patients with mild-to-moderate type 2 diabetes on oral antidiabetic drugs alone.
Zhang SL; Chen ZC; Yan L; Chen LH; Cheng H; Ji LN
Chin Med J (Engl); 2011 Aug; 124(16):2461-8. PubMed ID: 21933588
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects on glycaemic control and β-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial.
Chon S; Rhee SY; Ahn KJ; Baik SH; Park Y; Nam MS; Lee KW; Yoo SJ; Koh G; Lee DH; Kim YS; Woo JT;
Diabetes Obes Metab; 2018 May; 20(5):1121-1130. PubMed ID: 29272062
[TBL] [Abstract][Full Text] [Related]
7. Glycemic control and safety in Chinese patients with type 2 diabetes mellitus who switched from premixed insulin to insulin glargine plus oral antidiabetics: a large, prospective, observational study.
Zhang B; Zhao J; Yang W;
Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27667797
[TBL] [Abstract][Full Text] [Related]
8. Association of diabetes treatment with long-term glycemic patterns in patients with type 2 diabetes mellitus: A prospective cohort study.
Luo M; Tan CS; Lim WY; Chia KS; Tang WE; Tai ES; Venkataraman K
Diabetes Metab Res Rev; 2019 May; 35(4):e3122. PubMed ID: 30600922
[TBL] [Abstract][Full Text] [Related]
9. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of illness perceptions and their associations with glycaemic control, medication adherence and chronic kidney disease in type 2 diabetes mellitus patients in Malaysia.
Balasubramaniam S; Lim SL; Goh LH; Subramaniam S; Tangiisuran B
Diabetes Metab Syndr; 2019; 13(4):2585-2591. PubMed ID: 31405680
[TBL] [Abstract][Full Text] [Related]
11. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
12. Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial.
Tuttle KR; Lakshmanan MC; Rayner B; Busch RS; Zimmermann AG; Woodward DB; Botros FT
Lancet Diabetes Endocrinol; 2018 Aug; 6(8):605-617. PubMed ID: 29910024
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Glycemic Control, Lifestyle and Clinical Characteristics in Patients with Type 2 Diabetes Treated at King Abdullah University Hospital in Jordan.
Al-Eitan LN; Nassar AM; Saadeh NA; Almomani BA
Can J Diabetes; 2016 Dec; 40(6):496-502. PubMed ID: 27212046
[TBL] [Abstract][Full Text] [Related]
14. Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK.
Boye KS; Stein D; Matza LS; Jordan J; Yu R; Norrbacka K; Hassan SW; García-Pérez LE
Drugs R D; 2019 Jun; 19(2):213-225. PubMed ID: 31115873
[TBL] [Abstract][Full Text] [Related]
15. Rate of glycaemic control and associated factors in patients with type 2 diabetes mellitus treated with insulin-based therapy at selected hospitals in Northwest Ethiopia: a multicentre cross-sectional study.
Sendekie AK; Belachew EA; Dagnew EM; Netere AK
BMJ Open; 2022 Sep; 12(9):e065250. PubMed ID: 36691186
[TBL] [Abstract][Full Text] [Related]
16. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
[TBL] [Abstract][Full Text] [Related]
17. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D
Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669
[TBL] [Abstract][Full Text] [Related]
18. The role of vitamin D, obesity and physical exercise in regulation of glycemia in Type 2 Diabetes Mellitus patients.
Bener A; Al-Hamaq AO; Kurtulus EM; Abdullatef WK; Zirie M
Diabetes Metab Syndr; 2016; 10(4):198-204. PubMed ID: 27381964
[TBL] [Abstract][Full Text] [Related]
19. Trends in medication utilization, glycemic control and outcomes among type 2 diabetes patients in a tertiary referral center in Singapore from 2007 to 2017.
Tan YZ; Cheen MHH; Goh SY; Bee YM; Lim PS; Khee GY; Thumboo J
J Diabetes; 2019 Jul; 11(7):573-581. PubMed ID: 30556375
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment.
Mata-Cases M; Franch-Nadal J; Real J; Gratacòs M; López-Simarro F; Khunti K; Mauricio D
Diabetes Obes Metab; 2018 Jan; 20(1):103-112. PubMed ID: 28656746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
